Completed PHASE4 INTERVENTIONAL 1-arm NCT05155436

Occurrence of Dyskalemia With Treatment for Hypertension (OK)

Prevalence and Incidence of Dyskalemia in Hypertensive Patients Initiating a Fixed Dose Combination Pill of Telmisartan and Amlodipine

Sponsor: Johns Hopkins University

Conditions Hypertension Potassium Imbalance

Interventions Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg

Updated 6 times since 2022 Last updated: Jul 13, 2023 Started: Jan 15, 2022 Primary completion: Mar 31, 2023 Completion: Mar 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05155436, this PHASE4 trial focuses on Hypertension and Potassium Imbalance and remains completed. Sponsored by Johns Hopkins University, it has been updated 6 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Jun 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Jun 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Aug 2023 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Mar 2022 — Aug 2023 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jan 2022 — Mar 2022 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University
National Heart Foundation Hospital and Research Institute of Bangladesh
National Heart Foundation of Bangladesh
Resolve to Save Lives

Data source: National Heart Foundation of Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh